SMAD6 and colonic neoplasm: Because ~80% of colon cancer cell lines have some defects in the TGF-β signaling pathway through multiple mechanisms such as mutations in receptors, mutations in SMAD proteins, or overexpression of inhibitory SMAD6 or SMAD7 proteins35.